Z-2521-2025 Class II Ongoing

Recalled by CARIS LIFE SCIENCES — Tempe, AZ

FDA device recall Z-2521-2025 was initiated by CARIS LIFE SCIENCES on Jun 17, 2025 and is designated Class II. Reason for recall: Due to an incorrect test results provided that indicated the incorrect drug therapy recommendation The recall status is ongoing. Affected quantity: 1.

Recall details

Product Type
Devices
Report Date
Sep 10, 2025
Initiation Date
Jun 17, 2025
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
1

Product description

MI Cancer Seek REF MSC000 UDI Code: (01)00860008613325(21)H5HJHDSXF MI Cancer Seek is a single-site assay intended to provide tumor mutational profiling to be used by qualified healthcare professionals in accordance with professional oncology guidelines for cancer patients with previously diagnosed solid malignant neoplasms.

Reason for recall

Due to an incorrect test results provided that indicated the incorrect drug therapy recommendation

Distribution pattern

U.S. Nationwide distribution in the state of NY.

Code information

Catalog Number: MSC000 UDI Code: (01)00860008613325(21)H5HJHDSXF Serial Number: H5HJHDSXF

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-2521-2025
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-2521-2025. Report a data issue: hello@regdatalab.com.